Table 1 Emerging R&D activities in the Chinese pharmaceutical industry
From: Public funding and private investment for R&D: a survey in China’s pharmaceutical industry
2000 | 2005 | 2007 | 2008 | 2009 | 2010 | 2011 | |
|---|---|---|---|---|---|---|---|
Personnel for scientific and technologic (S&T) activities | 37,833 | 51,832 | 73,408 | 90,820 | 90,222 | 70,781 | 118,558 |
Patent applications | 547 | 2,708 | 3,056 | 3,917 | 8,601 | 5,767 | 11,115 |
R&D expenditure (100 million CNY) | 13.46 (163 million USD) | 39.95 (494 million USD) | 65.90 (889 million USD) | 79.10 (1155 million USD) | 135.00 (2045 million USD) | 122.60 (1851 million USD) | 211.20 (3,352 million USD) |